TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scandinavian Biopharma Distribution AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
102,015
|
103,694
|
81,384 |
| Financial expenses |
377
|
266
|
335 |
| Earnings before taxes |
17,694
|
20,650
|
21,232 |
| EBITDA |
17,712
|
20,425
|
21,521 |
| Total assets |
51,189
|
56,094
|
45,243 |
| Current assets |
51,032
|
55,353
|
44,951 |
| Current liabilities |
14,196
|
17,871
|
18,715 |
| Equity capital |
656
|
648
|
634 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
1.3%
|
1.2%
|
1.4% |
| Turnover per employee |
20,403
|
25,924
|
27,128 |
| Profit as a percentage of turnover |
17.3%
|
19.9%
|
26.1% |
| Return on assets (ROA) |
35.3%
|
37.3%
|
47.7% |
| Current ratio |
359.5%
|
309.7%
|
240.2% |
| Return on equity (ROE) |
2697.3%
|
3186.7%
|
3348.9% |
| Change turnover |
1,750
|
21,891
|
18,368 |
| Change turnover % |
2%
|
27%
|
29% |
| Chg. No. of employees |
1
|
1
|
0 |
| Chg. No. of employees % |
25%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.